CompletedNot Applicable

Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus

Pakistan138 participantsStarted 2024-11-01

Plain-language summary

Since there is a significant degree of variability in the results of previous studies and there exists a thirst for local data regarding this topic, the current study was planned, with the objective of comparing the efficacy of levetiracetam versus valproic acid in pediatric patients with status epilepticus.

Who can participate

Age range2 Years – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any gender * Aged 2-14 years * Presenting with status epilepticus Exclusion Criteria: * Patients with focal seizures * Patients already using valproic acid or levetiracetam * Patients with a history of hypersensitivity to either drug

What they're measuring

Sustained control of seizure activity

Timeframe: 24 hours

Trial details

NCT IDNCT07052136

SponsorRESnTEC, Institute of Research

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Status Epilepticus trials